EYE001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EYE001, covering 2007-05-07 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome [Phase 1]